title: Epidemiology and prevention of nosocomial pneumonia associated with Panton-Valentine Leukocidin (PVL) producing Staphylococcus aureus in Departmental Hospital Centre of Zou Collines in Benin.
abstract: BACKGROUND
  An eight (8) months prospective study was carried out to control an outbreak of nosocomial pneumonia due to a Panton-Valentine Leukocidin (PVL) producing Staphylococcus aureus, in the paediatrics' unit at the Zou/Collines Departmental Hospital (CHDZ/C), (Benin).
  
  
  METHODS
  Between 1(st) September 2004 and 30(th) May 2005 an investigation was conducted that involved the screening of all patients suspected to have nosocomial pneumonia, hospital environment sampling and the follow-up of cases until the end of hospital admission period. Isolates were identified, tested for antimicrobial susceptibility and analysed for PVL production. The study period was divided into Period I, corresponding to the outbreak period and Period II, after the complete renovation of the Unit along with hand washing promotion.
  
  
  RESULTS
  A total of 453 patients were admitted during the period of the study; (235 during Period I and 218 during Period II) in the malnourished children sector. Twenty eight (28) cases of pneumonia due to S. aureus were discovered and PVL-producing S. aureus constituted 61% (17/28) of identified cases. The mortality rate among the PVL- producing strains was 15/17 (88%) while it was 1/11 (9%) among non PVL-producing strains. Enhanced hygiene measures helped to terminate the outbreak.
  
  
  CONCLUSIONS
  This study showed that PVL was strongly linked to nosocomial pneumonia. PVL-producing S aureus can be controlled in the hospital by a combination of the promotion of preventive measures, decontamination of the environment and the early use of the correct antibiotic at the appropriate dose and for an adequate duration.
authors: Laboratoire de Biologie Humaine EPAC/UAC BP 2009, Université d'Abomey-Calavi, 04BP0320 Cotonou, Benin.
authors: T A
authors: TA
authors: Ahoyo
authors: A
authors: A
authors: Martin-Odoom
authors: H S
authors: HS
authors: Bankolé
authors: L
authors: L
authors: Baba-Moussa
authors: N
authors: N
authors: Zonon
authors: F
authors: F
authors: Loko
authors: Gilles
authors: G
authors: Prevost
authors: Ambaliou
authors: A
authors: Sanni
authors: K
authors: K
authors: Dramane
mesh_terms: D001427:Bacterial Toxins / Q000096:biosynthesis*; D001541:Benin / Q000453:epidemiology; D002648:Child; D015362:Child Nutrition Disorders / Q000150:complications; D003428:Cross Infection / Q000382:microbiology* / Q000401:mortality* / Q000517:prevention & control; D024881:Drug Resistance, Bacterial; D004866:Equipment Contamination / Q000517:prevention & control; D005098:Exotoxins / Q000096:biosynthesis*; D005260:Female; D006225:Hand / Q000382:microbiology; D006761:Hospitals; D006801:Humans; D007956:Leukocidins / Q000096:biosynthesis*; D008297:Male; D008826:Microbial Sensitivity Tests; D011023:Pneumonia, Staphylococcal / Q000382:microbiology* / Q000401:mortality* / Q000517:prevention & control; D011446:Prospective Studies; D013211:Staphylococcus aureus / Q000302:isolation & purification / Q000378:metabolism*
chemical_list: D001427:Bacterial Toxins; D005098:Exotoxins; D007956:Leukocidins; C078284:Panton-Valentine leukocidin
keywords: Necrotizing pneumonia; Panton-Valentine Leukocidin; S aureus Prevention
references: Arch Dermatol. 1994 Sep;130(9):1208-9
references: 8085883
references: Clin Infect Dis. 1999 Nov;29(5):1128-32
references: 10524952
references: Chest. 1990 Apr;97(4):788-92
references: 2323247
references: J Hosp Infect. 2006 May;63(1):93-100
references: 16542756
references: Infect Control Hosp Epidemiol. 1994 Jul;15(7):428-34
references: 7963432
references: Arch Intern Med. 1974 Jul;134(1):106-11
references: 4365670
references: Science. 2007 Feb 23;315(5815):1130-3
references: 17234914
references: Lancet. 2002 Mar 2;359(9308):753-9
references: 11888586
references: Intensive Care Med. 1998 Feb;24(2):189
references: 9539080
references: Arch Pediatr. 2006 Nov;13(11):1391-6
references: 16934963
references: FEBS Lett. 1998 Oct 2;436(2):202-8
references: 9781679
references: J Hosp Infect. 1999 Oct;43(2):85-100
references: 10549308
references: J Hosp Infect. 1999 Sep;43(1):13-7
references: 10462634
references: BMJ. 2005 Nov 12;331(7525):1107
references: 16282407
references: Infect Control Hosp Epidemiol. 1991 Jan;12(1):46-54
references: 1999643